Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
13.00
+0.59 (4.75%)
At close: Apr 27, 2026, 4:00 PM EDT
12.97
-0.03 (-0.23%)
After-hours: Apr 27, 2026, 4:10 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $485.37 million as of April 27, 2026. Its market cap has increased by 306.08% in one year.
Market Cap
485.37M
Enterprise Value
229.60M
1-Year Change
306.08%
Ranking
Category
Stock Price
$13.00
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $485.37M, an increase of 20.71%. That is a compound annual growth rate of 9.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 463.34M | 10.97% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 479.88M |
| Candel Therapeutics | 476.11M |
| Armata Pharmaceuticals | 473.30M |
| Prelude Therapeutics | 472.60M |
| Larimar Therapeutics | 471.63M |
| Valneva SE | 470.89M |
| Aura Biosciences | 466.73M |
| Ginkgo Bioworks Holdings | 458.09M |